Here's Why Inspire Medical Systems (INSP) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
How Much Upside is Left in Inspire (INSP)? Wall Street Analysts Think 25.88%
The consensus price target hints at a 25.9% upside potential for Inspire (INSP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
INSP Stock Declines Despite Q4 Earnings Beat, Gross Margin Contracts
Inspire Medical's both geographic segments witness strong revenue growth on the back of solid product demand in the fourth quarter.
Inspire Medical Systems, Inc. (INSP) Q4 2024 Earnings Call Transcript
Inspire Medical Systems, Inc. (NYSE:INSP ) Q4 2024 Earnings Conference Call February 10, 2025 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Securities Danielle Antalffy - UBS Robbie Marcus - JPMorgan Chris Pasquale - Nephron Research Anthony Petrone - Mizuho Financial Group Richard Newitter - Truist Securities David Rescott - Baird Adam Maeder - Piper Sandler Larry Biegelsen - Wells Fargo Shagun Singh - RBC Capital Markets Brett Fishbin - KeyBanc Capital Markets Jon Block - Stifel Michael Polark - Wolfe Research Mike Kratky - Leerink Partners Suraj Kalia - Oppenheimer & Co. Operator Good afternoon. My name is Dilem [ph] and I'll be your conference operator today.
Inspire Medical's Earnings Surge in Q4
Inspire Medical Systems (INSP -0.64%), known for its innovative devices that use neurostimulation to treat sleep apnea, announced impressive fourth-quarter results on Feb. 10. Earnings per share (EPS) came in at $1.15, well ahead of the $0.73 consensus estimate.
Inspire (INSP) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Inspire (INSP) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Inspire Medical Systems (INSP) Q4 Earnings and Revenues Surpass Estimates
Inspire Medical Systems (INSP) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.49 per share a year ago.
Countdown to Inspire (INSP) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Beyond analysts' top -and-bottom-line estimates for Inspire (INSP), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.
Inspire Medical Systems (INSP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Inspire Medical Stock Falls Despite Solid Preliminary Q4 Revenues
INSP's revenue growth in the fourth quarter is likely to have been boosted by increased market penetration in existing centers and expansion into new implanting centers.
Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade
BofA Securities has upgraded Inspire Medical Systems, Inc. INSP and says the company now falls in the profitable growth category.
